CALCIUM-ANTAGONIST AGENTS IN HYPERTROPHIC CARDIOMYOPATHY

被引:16
作者
CHATTERJEE, K
机构
关键词
D O I
10.1016/0002-9149(87)90095-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:B146 / B152
页数:7
相关论文
共 27 条
[21]   VERAPAMIL THERAPY - NEW APPROACH TO THE PHARMACOLOGIC TREATMENT OF HYPERTROPHIC CARDIOMYOPATHY .1. HEMODYNAMIC-EFFECTS [J].
ROSING, DR ;
KENT, KM ;
BORER, JS ;
SEIDES, SF ;
MARON, BJ ;
EPSTEIN, SE .
CIRCULATION, 1979, 60 (06) :1201-1207
[22]   VERAPAMIL THERAPY - NEW APPROACH TO THE PHARMACOLOGIC TREATMENT OF HYPERTROPHIC CARDIOMYOPATHY .2. EFFECTS ON EXERCISE CAPACITY AND SYMPTOMATIC STATUS [J].
ROSING, DR ;
KENT, KM ;
MARON, BJ ;
EPSTEIN, SE .
CIRCULATION, 1979, 60 (06) :1208-1213
[23]  
RUDDY TD, 1982, CIRCULATION, V66, P24
[24]  
SONNTAG F, 1981, EUR HEART J SUPPL, V2, P193
[25]  
TROESCH M, 1979, CIRCULATION S2, V59, P155
[26]   HEMODYNAMIC DETERMINANTS OF MAXIMUM NEGATIVE DP-DT AND PERIODS OF DIASTOLE [J].
WEISFELD.ML ;
SCULLY, HE ;
FREDERIK.J ;
RUBENSTE.JJ ;
POHOST, GM ;
BEIERHOL.E ;
BELLO, AG ;
DAGGETT, WM .
AMERICAN JOURNAL OF PHYSIOLOGY, 1974, 227 (03) :613-621
[27]   HYPERTROPHIC CARDIOMYOPATHY - THE IMPORTANCE OF THE SITE AND THE EXTENT OF HYPERTROPHY - A REVIEW [J].
WIGLE, ED ;
SASSON, Z ;
HENDERSON, MA ;
RUDDY, TD ;
FULOP, J ;
RAKOWSKI, H ;
WILLIAMS, WG .
PROGRESS IN CARDIOVASCULAR DISEASES, 1985, 28 (01) :1-83